openPR Logo
Press release

Heparin Market is driven by increasing demand for blood clotting disorders | B. Braun Holding GmbH & Co. KG, Dr. Reddy's Laboratories Ltd., Fresenius SE & Co

06-12-2023 05:00 AM CET | Health & Medicine

Press release from: Global Insight Services

Heparin Market

Heparin Market

Heparin is a medication that is used to treat and prevent blood clots. It works by binding to a substance in the blood called thrombin, which is responsible for clotting. Heparin can be given intravenously (by IV) or subcutaneously (under the skin). The IV form is used for treating blood clots, while the subcutaneous form is used for preventing blood clots. Heparin is a very effective medication, but it can cause serious side effects, including bleeding.

Request sample copy of this research study: https://www.globalinsightservices.com/checkout/single_user/GIS21871

Key Trends

The key trends in heparin technology are:

1. The development of new and more effective heparin products
2. The increasing use of heparin in a wide range of medical conditions
3. The increasing use of heparin in combination with other drugs
4. The increasing use of heparin in the prevention and treatment of thrombosis

Read more about Heparin market here: https://www.globalinsightservices.com/reports/heparin-market/

Key Drivers

The key drivers of the heparin market are the rising incidence of blood clotting disorders, the increasing number of surgical procedures, and the growing preference for minimally invasive surgeries. Additionally, the availability of biosimilar products is expected to boost the growth of the heparin market.

The rising incidence of blood clotting disorders is the major factor driving the growth of the heparin market. According to the National Blood Clot Alliance, the incidence of venous thromboembolism (VTE), which includes deep vein thrombosis (DVT) and pulmonary embolism (PE), is estimated to be around 1 in every 1000 people in the United States.

The increasing number of surgical procedures is another factor driving the heparin market. According to the American Society of Anesthesiologists, the number of surgical procedures performed in the United States is expected to reach 60 million by 2020. This is due to the growing number of minimally invasive surgeries being performed. Additionally, the number of hip and knee replacement surgeries is expected to grow significantly over the next decade.

Get Customized Report as Per Your Requirement: https://www.globalinsightservices.com/request-customization/GIS21871

The growing preference for minimally invasive surgeries is another factor driving the growth of the heparin market. Minimally invasive surgeries are associated with a lower risk of complications and a shorter hospital stay. Furthermore, these surgeries are associated with a lower risk of blood loss and a quicker recovery.

The availability of biosimilar products is expected to boost the growth of the heparin market. Biosimilar products are expected to offer a more affordable alternative to branded products. Additionally, biosimilar products are expected to have a similar efficacy and safety profile as the branded products.

Market Segmentation

The Heparin Market market segmented by product, application, distribution channel, and region. On the basis of product, the market is categorized into unfractionated heparin, low molecular weight heparin (LMWH), and ultra-low molecular weight heparin (ULMWH). By application, it is classified into venous thromboembolism, atrial fibrillation, coronary artery disease, and others. By distribution channel, it is divided into hospital pharmacies, drug stores & retail pharmacies, and online pharmacies. Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and rest of the world.

Buy now : https://www.globalinsightservices.com/checkout/single_user/GIS21871

Key Players

The key players in the Heparin Market are Baxter International Inc., B. Braun Holding GmbH & Co. KG, Dr. Reddy's Laboratories Ltd., Fresenius SE & Co KGaA, Hebei Changshan Biochemical Pharmaceutical Co., Ltd., Leo Pharma A/S, Pfizer Inc., Sanofi S.A, Teva Pharmaceuticals, and Viatris Inc.

With Global Insight Services, you receive:

10-year forecast to help you make strategic decisions
In-depth segmentation which can be customized as per your requirements
Free consultation with lead analyst of the report
Excel data pack included with all report purchases
Robust and transparent research methodology

New Report Published by Global Insight Services: https://www.globalinsightservices.com/reports/hydrogen-projects-database/

About Global Insight Services:

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust and transparent research methodology, and superior service.

Contact Us:

Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Heparin Market is driven by increasing demand for blood clotting disorders | B. Braun Holding GmbH & Co. KG, Dr. Reddy's Laboratories Ltd., Fresenius SE & Co here

News-ID: 3084459 • Views:

More Releases from Global Insight Services

Immuno Oncology Drugs Market Projected to Reach $634.1 Billion by 2034, Growing at 17.5% CAGR | Overall Study Report
Immuno Oncology Drugs Market Projected to Reach $634.1 Billion by 2034, Growing …
The Immuno Oncology Drugs Market is rapidly emerging as a transformative segment in the global healthcare industry. These drugs harness the body's immune system to identify and attack cancer cells, offering innovative treatment alternatives to traditional chemotherapy and radiation therapies. Immuno-oncology therapies include monoclonal antibodies, checkpoint inhibitors, cancer vaccines, and cell-based therapies such as CAR-T cells. The growth of this market is primarily driven by advancements in biotechnology, an improved
GLP 1 Market Projected to Reach $221.8 Billion by 2034, Growing at 9% CAGR | Overall Study Report
GLP 1 Market Projected to Reach $221.8 Billion by 2034, Growing at 9% CAGR | Ove …
The GLP 1 Market is experiencing unprecedented growth, fueled by the rising prevalence of type 2 diabetes and obesity globally. GLP-1, or glucagon-like peptide-1 receptor agonists, represents a groundbreaking therapeutic class that improves insulin secretion, reduces glucagon production, and slows gastric emptying. These mechanisms not only enhance glycemic control but also support weight management, making GLP-1 therapies a preferred choice among healthcare providers and patients alike. Over the years, the
Autonomous Bus Market to Expand to $11.6 Billion by 2034, Advancing at 18.8% CAGR | Key Players: EasyMile, Navya, Aurrigo
Autonomous Bus Market to Expand to $11.6 Billion by 2034, Advancing at 18.8% CAG …
Market Overview Autonomous Bus Market is revolutionizing the future of urban mobility through advanced automation technologies. Valued at $2.1 billion in 2024, the market is projected to reach $11.6 billion by 2034, expanding at a strong CAGR of 18.8%. This market focuses on the development and deployment of self-driving buses equipped with cutting-edge sensors, artificial intelligence, and vehicle-to-everything (V2X) communication systems. These buses are designed to improve road safety, enhance passenger
Automotive Tire Market to Attain $976.7 Billion by 2034, Growing at 9.2% CAGR | Key Players: Apollo Tyres, Nokian Tyres, Hankook Tire
Automotive Tire Market to Attain $976.7 Billion by 2034, Growing at 9.2% CAGR | …
Market Overview Automotive Tire Market is experiencing remarkable growth as the industry embraces innovation, sustainability, and digital transformation. Valued at $406 billion in 2024, the market is projected to soar to $976.7 billion by 2034, reflecting a CAGR of 9.2%. This expansion is primarily driven by the surge in global vehicle production, growing consumer preference for durable and high-performance tires, and the increasing adoption of smart tire technologies. The Automotive Tire

All 5 Releases


More Releases for Heparin

Heparin (Heparin Sodium and Heparin Calcium) Market Size, Overview And Forecast …
"The Global Heparin (Heparin Sodium and Heparin Calcium) Market Size is projected to reach at a CAGR of 3.4% during 2024-2032." Global Heparin (Heparin Sodium and Heparin Calcium) market Size, Status, and Forecast for the 2024-2032. In-depth research has been compiled to provide the most up-to-date information on key aspects of the worldwide market. This research report covers major aspects of the Heparin (Heparin Sodium and Heparin Calcium) Market including
Heparin (Heparin Sodium and Heparin Calcium) Market explores demand trends, grow …
"𝐄𝐦𝐩𝐨𝐰𝐞𝐫𝐢𝐧𝐠 𝐁𝐮𝐬𝐢𝐧𝐞𝐬𝐬𝐞𝐬 𝐰𝐢𝐭𝐡 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐯𝐞 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐨𝐥𝐮𝐭𝐢𝐨𝐧𝐬 𝐟𝐨𝐫 𝐒𝐦𝐚𝐫𝐭𝐞𝐫 𝐃𝐞𝐜𝐢𝐬𝐢𝐨𝐧-𝐌𝐚𝐤𝐢𝐧𝐠" The global Heparin (Heparin Sodium and Heparin Calcium) market is anticipated to grow from USD 1,202 Million in 2023 to USD 1,509 Million by 2033, at a CAGR of 3.3 % during the forecast period. Heparin (Heparin Sodium and Heparin Calcium) 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐢𝐳𝐞, 𝐒𝐜𝐨𝐩𝐞, 𝐚𝐧𝐝 𝐅𝐨𝐫𝐞𝐜𝐚𝐬𝐭 𝟐𝟎𝟐𝟒-𝟐𝟎𝟑𝟑 𝐫𝐞𝐩𝐨𝐫𝐭 𝐡𝐚𝐬 𝐛𝐞𝐞𝐧 𝐢𝐧𝐜𝐥𝐮𝐝𝐞𝐝 𝐢𝐧 𝐄𝐱𝐚𝐜𝐭𝐢𝐭𝐮𝐝𝐞 𝐂𝐨𝐧𝐬𝐮𝐥𝐭𝐚𝐧𝐜𝐲'𝐬 𝐦𝐚𝐫𝐤𝐞𝐭 𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐜𝐨𝐥𝐥𝐞𝐜𝐭𝐢𝐨𝐧. Heparin (Heparin Sodium and Heparin Calcium) Market
Heparin Market Report 2023 | Increasing the Advantages of Low Molecular Weight H …
According to Precision Business Insights (PBI), the latest report the global heparin market size was valued at USD 7,923.7 million in 2022 and is projected to grow at a 2.8% CAGR during the forecast period 2023 to 2029. The efficacy of these drugs as an anticoagulant is one of the key factors expected to drive global market growth. Furthermore, undeniable factors such as technological advancement and introducing of new products
Heparin Market
The heparin market refers to the global market for heparin, a blood-thinning medication that is commonly used in the prevention and treatment of blood clots. Heparin is typically derived from the mucous membranes of animals such as pigs and cows, and it is commonly used in a variety of medical settings, including hospitals, clinics, and home care settings. The heparin market has experienced steady growth over the past few years, driven
Global Heparin(Heparin Sodium and Heparin Calcium) Market drivers, restraints, g …
Latest industry research report on: Global Heparin(Heparin Sodium and Heparin Calcium) Market : Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts This report studies the global Heparin(Heparin Sodium and Heparin Calcium) market status and forecast, categorizes the global Heparin(Heparin Sodium and Heparin Calcium) market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China,
Heparin Market: Rapid Growth of Heparin Market Anticipated in Several European N …
Europe is among the major regions contributing to the global heparin market owing to its developed economy and high prevalence of coagulation disorders. According to the Ageing Report published by the European Commission in 2015, the percentage of population aged above 65 years is expected to increase from 21.0% in 2013 to 32.0% in 2060. Aging is directly proportional to the rising incidence of venous thromboembolism (VTE) diseases such as